Probiotics and inflammatory bowel diseases;Probiotiques et maladies inflammatoires chroniques intestinales

Cahiers de Nutrition et de Dietetique

Volumn 42, Issue 2 SPEC. ISS., 2007, Pages

  Seksik, Philippe ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Adaptive immunity; Crohn's disease; Dysbiosis; Inflammatory bowel diseases (IBD); Innate immunity; Intestinal microbiota; Pouchitis; Probiotics; Ulcerative colitis

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN A; PROBIOTIC AGENT;

ABDOMINAL PAIN; ADAPTIVE IMMUNITY; BACTERIAL STRAIN; CLINICAL FEATURE; CROHN DISEASE; CYTOKINE RELEASE; DIARRHEA; DISEASE CONTROL; ENTERITIS; EPITHELIUM CELL; EUKARYOTE; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; INTESTINE FLORA; NONHUMAN; PATHOPHYSIOLOGY; PH; PROKARYOTE; RECOGNITION; REMISSION; REVIEW;

EUKARYOTA; PROKARYOTA;

EID: 34347266575     PISSN: 00079960     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0007-9960(07)91322-X     Document Type: Review

References (59)

1. Shivananda S., Lennard-Jones J., Logan R., Fear N., Price A., Carpenter L., van Blankenstein M. - Incidence of inflammatory bowel disease across Europe: is there a difference between North and South? Results of the European Collaborative Study on Inflammatory Bowel Disease (ECIBD). Gut., 1996, 39, 690-7.
2. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., Thomas G. - Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 2001, 411, 599-603.
3. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., Abraham C., Regueiro M., Griffiths A., Dassopoulos T., Bitton A., Yang H., Targan S., Datta L.W., Kistner E.O., Schumm L.P., Lee A., Gregersen P.K., Barmada M.M., Rotter J.I., Nicolae D.L., Cho J.H. - A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene. Science, 2006.
4. Hue S., Ahern P., Buonocore S., Kullberg M.C., Cua D.J., McKenzie B.S., Powrie F., Maloy K.J. - Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med., 2006, 203, 2473-83.
5. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. - Host-bacterial mutualism in the human intestine. Science, 2005, 307, 1915-20.
6. Harris G., Kuolee R., Chen W. - Role of Toll-like receptors in health and diseases of gastrointestinal tract. World J. Gastro-enterol., 2006, 12, 2149-60.
7. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Granucci F., Kraehenbuhl J.P., Ricciardi-Castagnoli P. - Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2001, 2, 361-7.
8. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. - Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell., 2004, 118, 229-41.
9. Marteau P., Seksik P., Shanahan F. - Manipulation of the bacterial flora in inflammatory bowel disease. Best Pract. Res. Clin. Gastro-enterol., 2003, 17, 47-61.
10. Ehrhardt R.O., Ludviksson B.R., Gray B., Neurath M., Strober W. - Induction and prevention of colonic inflammation in IL-2-deficient mice. J. Immunol., 1997, 158, 566-73.
11. Elson C.O., Sartor R.B., Tennyson G.S., Riddell R.H. - Experimental models of inflammatory bowel disease. Gastro-enterology, 1995, 109, 1344-67.
12. Shanahan F. - Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflamm. Bowel. Dis., 2000, 6, 107-15.
13. Rutgeerts P., Goboes K., Peeters M., Hiele M., Penninckx F., Aerts R., Kerremans R., Vantrappen G. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet, 1991, 338, 771-4.
14. D'Haens G.R., Geboes K., Peeters M., Baert F., Penninckx F., Rutgeerts P. - Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastro-enterology, 1998, 114, 262-7.
15. Gionchetti P., Rizzello F., Venturi A., Ugolini F., Rossi M., Brigidi P., Johansson R., Ferrieri A., Poggioli G., Campieri M. - Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment. Pharmacol. Ther., 1999, 13, 713-8.
16. Marteau P., Shanahan F. - Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. Best Pract. Res. Clin. Gastro-enterol., 2003, 17, 725-40.
17. Borruel N., Carol M., Casellas F., Antolin M., de Lara F., Espin E., Naval J., Guarner F., Malagelada J.R. - Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut., 2002, 51, 659-64.
18. Kim S.C., Tonkonogy S.L., Albright C.A., Tsang J., Balish E.J., Braun J., Huycke M.M., Sartor R.B. - Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastro-enterology 2005, 128, 891-906.
19. Seksik P., Rigottier-Gois L., Gramet G., Sutren M., Pochart P., Marteau P., Jian R., Doré J. - Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut., 2003, 52, 237-42.
20. Sokol H., Seksik P., Rigottier-Gois L., Lay C., Lepage P., Podglajen I., Marteau P., Doré J. - Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm. Bowel. Dis. 2006, 12, 106-11.
21. Tamboli C.P., Neut C., Desreumaux P., Colombel J.F. - Dysbiosis in inflammatory bowel disease. Gut., 2004, 53, 1-4.
22. Rath H.C., Wilson K.H., Sartor R.B. - Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect. Immun., 1999, 67, 2969-74.
23. Rath H.C., Herfarth H.H., Ikeda J.S., Grenther W.B., Hamm T.E., Jr., Balish E., Taurog J.D., Hammer R.E., Wilson K.H., Sartor R.B. - Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J. Clin. Invest., 1996, 98, 945-53.
24. Sokol H., Lepage P., Seksik P., Doré J., Marteau P. - Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J. Clin. Microbiol. 2006, 44, 3172-7.
25. Ott S.J., Schreiber S. - Reduced microbial diversity in inflammatory bowel diseases. Gut., 2006, 55, 1207.
26. Prindiville T., Cantrell M., Wilson K.H. - Ribosomal DNA sequence analysis of mucosa-associated bacteria in Crohn's disease. Inflamm. Bowel. Dis. 2004, 10, 824-33.
27. Manichanh C., Rigottier-Gois L., Bonnaud E., Gloux K., Pelletier E., Frangeul L., Nalin R., Jarrin C., Chardon P., Marteau P., Roca J., Doré J. - Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut., 2006, 55, 205-11.
28. Gionchetti P., Rizzello F., Venturi A., Brigidi P., Matteuzzi D., Bazzocchi G., Poggioli G., Miglioli M., Campieri M. - Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastro-enterology, 2000, 119, 305-9.
29. Mimura T., Rizzello F., Helwig U., Poggioli G., Schreiber S., Talbot I.C., Nicholls R.J., Gionchetti P., Campieri M., Kamm M.A. - Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut., 2004, 53, 108-14.
30. Gionchetti P., Rizzello F., Helwig U., Venturi A., Lammers K.M., Brigidi P., Vitali B., Poggioli G., Miglioli M., Campieri M. - Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastro-enterology, 2003, 124, 1202-9.
31. Kuisma J., Mentula S., Jarvinen H., Kahri A., Saxelin M., Farkkila M. - Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol. Ther., 2003, 17, 509-15.
32. Gosselink M.P., Schouten W.R., van Lieshout L.M., Hop W.C., Laman J.D., Ruseler-van Embden J.G. - Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Dis. Colon. Rectum., 2004, 47, 876-84.
33. Kruis W., Schutz E., Fric P., Fixa B., Judmaier G., Stolte M. - Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther. 1997, 11, 853-8.
34. Rembacken B.J., Snelling A.M., Hawkey P.M., Chalmers D.M., Axon A.T. - Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet, 1999, 354, 635-9.
35. Kruis W., Fric P., Pokrotnieks J., Lukas M., Fixa B., Kascak M., Kamm M.A., Weismueller J., Beglinger C., Stolte M., Wolff C., Schulze J. - Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut., 2004, 53, 1617-23.
36. Ishikawa H., Akedo I., Umesaki Y., Tanaka R., Imaoka A., Otani T. - Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J. Am. Coll. Nutr. 2003, 22, 56-63.
37. Malchow H.A. - Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J. Clin. Gastro-enterol, 1997, 25, 653-8.
38. Plein K., Hotz J. - Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea - a pilot study. Z Gastro-enterol., 1993, 31, 129-34.
39. Guslandi M., Mezzi G., Sorghi M., Testoni P.A. - Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis. Sci., 2000, 45, 1462-4.
40. Sazawal S., Hiremath G., Dhingra U., Malik P., Deb S., Black R.E. - Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet. Infect. Dis., 2006, 6, 374-82.
41. Prantera C., Scribano M.L., Falasco G., Andreoli A., Luzi C. - Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. Gut., 2002, 51, 405-9.
42. Bousvaros A., Guandalini S., Baldassano R.N., Botelho C., Evans J., Ferry G.D., Goldin B., Hartigan L., Kugathasan S., Levy J., Murray K.F., Oliva-Hemker M., Rosh J.R., Tolia V., Zholudev A., Vanderhoof J.A., Hibberd P.L. - A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm. Bowel. Dis., 2005, 11, 833-9.
43. Marteau P., Lemann M., Seksik P., Laharie D., Colombel J.F., Bouhnik Y., Cadiot G., Soule J.C., Boureille A., Metman E., Lerebours E., Carbonnel F., Dupas J.L., Veyrac M., Coffin B., Moreau J., Abitbol V., Blum-Sperisen S., Mary J.Y. - Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double-blind, placebo-controlled GETAID trial. Gut., 2005.
44. Marteau P., Seksik P., Lepage P., Doré J. - Cellular and physiological effects of probiotics and prebiotics. Mini. Rev. Med. Chem., 2004, 4. 889-96.
45. Venturi A., Gionchetti P., Rizzello F., Johansson R., Zucconi E., Brigidi P., Matteuzzi D., Campieri M. - Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment. Pharmacol, Ther., 1999, 13, 1103-8.
46. Fukushima Y., Kawata Y., Hara H., Terada A., Mitsuoka T. - Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int. J. Food Microbiol., 1998, 42, 39-44.
47. Mack D.R., Lebel S. - Role of probiotics in the modulation of intestinal infections and inflammation. Curr. Opin. Gastro-enterol., 2004, 20, 22-6.
48. Mack D.R., Michail S., Wei S., McDougall L., Hollingsworth M.A. - Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol., 1999, 276, G941-50.
49. Flynn S., van Sinderen D., Thornton G.M., Holo H., Nes I.F., Collins J.K. - Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118. Microbiology, 2002, 148, 973-84.
50. Wehkamp J., Salzman N.H., Porter E., Nuding S., Weichenthal M., Petras R.E., Shen B., Schaeffeler E., Schwab M., Linzmeier R., Feathers R.W., Chu H., Lima H., Jr., Fellermann K., Ganz T., Stange E.F., Bevins C.L. - Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA, 2005, 102, 18129-34.
51. Peeters M., Geypens B., Claus D., Nevens H., Ghoos Y., Verbeke G., Baert F., Vermeire S., Vlietinck R., Rutgeerts P. - Clustering of increased small intestinal permeability in families with Crohn's disease. Gastro-enterology, 1997, 113, 802-7.
52. Madsen K., Cornish A., Soper P., McKaigney C., Jijon H., Yachimec C., Doyle J., Jewell L., De Simone C. - Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastro-enterology, 2001, 121, 580-91.
53. Neish AS. Bacterial inhibition of eukaryotic pro-inflammatory pathways. Immunol. Res., 2004, 29, 175-86.
54. McCarthy J., O'Mahony L., O'Callaghan L., Sheil B., Vaughan E.E., Fitzsimons N., Fitzgibbon J., O'Sullivan G.C., Kiely B., Collins J.K., Shanahan F. - Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut., 2003, 52, 975-80.
55. Pena J.A., Rogers A.B., Ge Z., Ng V., Li S.Y., Fox J.G., Versalovic J. - Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect. Immun., 2005, 73, 912-20.
56. Petrof E.O., Kojima K., Ropeleski M.J., Musch M.W., Tao Y., De Simone C., Chang E.B. - Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology, 2004, 127, 1474-87.
57. Schultz M., Strauch U.G., Linde H.J., Watzl S., Obermeier F., Gottl C., Dunger N., Grunwald N., Scholmerich J., Rath H.C. - Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clin. Diagn. Lab. Immunol., 2004, 11, 372-8.
58. Rigby R.J., Knight S.C., Kamm M.A., Stagg A.J. - Production of interleukin (IL) -10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli. Clin. Exp. Immunol., 2005, 139, 245-56.
59. Hart A.L., Al-Hassi H.O., Rigby R.J., Bell S.J., Emmanuel A.V., Knight S.C., Kamm M.A., Stagg A.J. - Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastro-enterology, 2005, 129, 50-65.